🕵️ TG Therapeutics, Inc. ($TGTX)
SEC insider & ownership activity, last 12 months · CIK 1001316 · every row links its SEC filing
Over the last 12 months insiders sold $438K with no open-market buying against it. Laurence N. Charney sold $275K in discretionary trades (Sep). State Street Corporation added 4.7% → 5.1%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $438K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Laurence N. Charney | 0 | – | 1 | $275K | Sep 10, 2026 |
| Echelard Yann | 0 | – | 1 | $163K | Nov 24, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12.8% | 13G | Apr 30, 2025 | filing ↗ | |
| Vanguard Portfolio Management | 5.3% | 13G | Apr 29, 2026 | filing ↗ | |
| State Street Corporation | 5.1% | 13G | Nov 10, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Laurence N. Charney | $275K | Sep 10, 2026 | filing ↗ |
| Echelard Yann | $163K | Nov 24, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 3, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Other events (8.01) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Other events (8.01) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 18, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 18, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 13, 2026 | filing ↗ |
| Earnings (2.02) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |